Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab

Background: Anti-IL-17A therapy is generally effectively applied in patients with Ankylosing Spondylitis (AS) to achieve and maintain remission. However, the influence of anti-IL-17A on the composition of the immune system is not apparent. Our prospective study was to explore the changes in immune i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yutong, Yang, Mingcan, Zhang, Yanli, Huang, Yefei, Wu, Jialing, Xie, Ya, Wei, Qiujing, Liao, Zetao, Gu, Jieruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551761/
https://www.ncbi.nlm.nih.gov/pubmed/34721027
http://dx.doi.org/10.3389/fphar.2021.738316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551761/
https://www.ncbi.nlm.nih.gov/pubmed/34721027
http://dx.doi.org/10.3389/fphar.2021.738316

Ejemplares similares